William W. Ericson - Mar 15, 2023 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Role
Director
Signature
/s/ Michele Farmer, Attorney-in-fact
Stock symbol
PACB
Transactions as of
Mar 15, 2023
Transactions value $
-$3,615
Form type
4
Date filed
3/17/2023, 05:31 PM
Previous filing
May 27, 2022
Next filing
May 26, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PACB Common Stock Options Exercise $63.5K +25K +1871.26% $2.54 26.3K Mar 15, 2023 Direct
transaction PACB Common Stock Sale -$67.1K -7.54K -28.63% $8.90 18.8K Mar 15, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PACB Stock Option (right to buy) Options Exercise $0 -25K -100% $0.00* 0 Mar 15, 2023 Common Stock 25K $2.54 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares sold to cover the exercise price of soon-to-expire stock options.
F2 This sale price represents the weighted average sale price of the shares sold ranging from $8.84 to $8.93 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3 The shares subject to the option are fully vested and exercisable.